Artificial Pancreas Device System Global Market Report 2025

Description

An Artificial Pancreas Device System (APDS) is a medical technology designed to automate blood glucose management for people with diabetes. This system combines continuous glucose monitoring (CGM) with an insulin pump and employs a sophisticated algorithm to adjust insulin delivery automatically based on real-time glucose readings. The goal of the device is to replicate the glucose-regulating function of a healthy pancreas, thus minimizing the need for manual blood glucose monitoring and insulin injections, and assisting in keeping blood glucose levels within a target range.

The artificial pancreas device system market features three main types of devices threshold suspend device systems, control-to-range systems, and control-to-target systems. Threshold suspend device systems are insulin pump technologies that automatically halt insulin delivery when blood glucose levels fall below a set threshold. The different treatment types include bi-hormonal, insulin-only, and hybrid systems, with end-users such as hospitals, medical centers, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The artificial pancreas device system market research report is one of a series of new reports from The Business Research Company that provides artificial pancreas device system market statistics, including the artificial pancreas device system industry global market size, regional shares, competitors with artificial pancreas device system market share, detailed artificial pancreas device system market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial pancreas device system industry. These artificial pancreas device system market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial pancreas device system market size has grown rapidly in recent years. It will grow from $1.81 billion in 2024 to $2.06 billion in 2025 at a compound annual growth rate (CAGR) of 13.8%. The growth in the historic period can be attributed to rising inflow of investment, growing government initiative in clinical research, growing demand for automated systems in glycemic control, intensive R&D efforts by industry players, and increasing geriatric population.

The artificial pancreas device system market size is expected to see rapid growth in the next few years. It will grow to $3.46 billion in 2029 at a compound annual growth rate (CAGR) of 13.8%. The growth in the forecast period can be attributed to growing prevalence of diabetes, increasing prevalence of pancreatic cancer, growing occurrence of diabetes and obesity, rising demand minimally invasive (MI) drug delivery systems, and driving innovation in diabetes management technology. Major trends in the forecast period include technological innovations, increasing research and development activities, increasing product approvals, partnerships and collaborations, and increasing activities in tele consultancy for follow-up.

The forecast of 13.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. diabetes management by driving up the cost of closed-loop insulin delivery systems and glucose prediction algorithms sourced from Switzerland and France, exacerbating treatment costs for Type 1 diabetes patients. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing incidence of pancreatic cancer is projected to drive the expansion of the artificial pancreas device system (APDS) market. Pancreatic cancer is a malignant tumor originating in the pancreas, which is located behind the stomach. The development of pancreatic cancer is influenced by a mix of lifestyle, genetic, medical, and environmental factors, including genetic mutations that can cause hereditary pancreatitis and result in chronic pancreatic inflammation. An artificial pancreas device system is primarily designed to assist individuals with diabetes in managing their blood sugar levels by automatically monitoring glucose and delivering the appropriate amount of insulin. For example, in March 2024, according to theCancer Australia, an Australia-based government agency, estimated that 4,506 new cases of pancreatic cancer were diagnosed in 2023, up from 3,751 cases over the previous five years. Thus, the rising prevalence of pancreatic cancer is contributing to the growth of the artificial pancreas device system market.

Key players in the artificial pancreas device system market are developing automated insulin delivery systems to improve diabetes management by automatically monitoring blood glucose levels and administering the correct amount of insulin. These systems aim to mimic the function of a healthy pancreas, alleviating the need for constant blood sugar monitoring and manual insulin injections. For instance, in May 2023, Beta Bionics, a US-based medical equipment manufacturer, received FDA 510(k) clearance for its iLet Insulin-Only Bionic Pancreas System, an automated insulin delivery device. This artificial pancreas system autonomously determines and delivers insulin doses to regulate blood glucose levels. The closed-loop system adjusts insulin delivery based on glucose levels measured by a connected continuous glucose monitor (CGM), requiring only the user's body weight and a meal size estimate for automatic adjustments.

In September 2023, Abbott Laboratories, a US-based pharmaceutical company, acquired Bigfoot Biomedical for an undisclosed amount. This acquisition strengthens Abbott's position in diabetes care by integrating its leading Freestyle Libre continuous glucose monitoring technology with Bigfoot Biomedical's expertise in automated insulin delivery systems. Bigfoot Biomedical, a US-based company, specializes in developing prototypes of automated insulin delivery systems, also known as artificial pancreas systems.

Major companies operating in the artificial pancreas device system market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, DexCom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Juvenile Diabetes Research Foundation (JDRF), Beta Bionics Inc., Glooko Inc., Bigfoot Biomedical Inc., CeQur SA, Medtrum Technologies Inc., Diabeloop SA, Beta-O2 Technologies Ltd, Pancreum Inc., TypeZero Technologies LLC, Inreda Diabetic B.V., Defymed SAS, Admetsys Corporation, DreaMed Diabetes Ltd

North America was the largest region in the artificial pancreas device system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial pancreas device system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial pancreas device system market includes revenues earned by entities by providing services such as patient monitoring, device maintenance, data management, software updates, healthcare provider consultations, and training and support for patients and healthcare professionals. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial pancreas device system market also includes sales of insulin pumps, continuous glucose monitors, control algorithms and software applications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Pancreas Device System Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial pancreas device system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial pancreas device system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial pancreas device system market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Device Type: Threshold Suspend Device Systems; Control-To-Range Systems; Control-To-Target Systems
2) By Treatment Type: Bi-Hormonal; Insulin Only; Hybrid
3) By End-User: Hospitals; Medical Centers; Other End-Users
Subsegments:
1) By Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend; Continuous Glucose Monitoring (CGM) Integrated Systems
2) By Control-To-Range Systems: Hybrid Closed-Loop Systems; Insulin Delivery Systems with Range Control; Real-Time Glucose Adjustment Systems
3) By Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems; Insulin Pumps with Targeted Glucose Control; Automated Glucose Regulation Systems
Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; DexCom Inc.; Insulet Corporation; Tandem Diabetes Care Inc.; Juvenile Diabetes Research Foundation (JDRF); Beta Bionics Inc.; Glooko Inc.; Bigfoot Biomedical Inc.; CeQur SA; Medtrum Technologies Inc.; Diabeloop SA; Beta-O2 Technologies Ltd; Pancreum Inc.; TypeZero Technologies LLC; Inreda Diabetic B.V.; Defymed SAS; Admetsys Corporation; DreaMed Diabetes Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r29437u

1. Executive Summary

2. Artificial Pancreas Device System Market Characteristics

3. Artificial Pancreas Device System Market Trends And Strategies

4. Artificial Pancreas Device System Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Pancreas Device System Growth Analysis And Strategic Analysis Framework

5.1. Global Artificial Pancreas Device System PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Artificial Pancreas Device System Market Growth Rate Analysis
5.4. Global Artificial Pancreas Device System Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Artificial Pancreas Device System Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Artificial Pancreas Device System Total Addressable Market (TAM)

6. Artificial Pancreas Device System Market Segmentation

6.1. Global Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Threshold Suspend Device Systems
Control-To-Range Systems
Control-To-Target Systems
6.2. Global Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bi-Hormonal
Insulin Only
Hybrid
6.3. Global Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Medical Centers
Other End-Users
6.4. Global Artificial Pancreas Device System Market, Sub-Segmentation Of Threshold Suspend Device Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Insulin Pump with Threshold Suspend
Continuous Glucose Monitoring (CGM) Integrated Systems
6.5. Global Artificial Pancreas Device System Market, Sub-Segmentation Of Control-To-Range Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hybrid Closed-Loop Systems
Insulin Delivery Systems with Range Control
Real-Time Glucose Adjustment Systems
6.6. Global Artificial Pancreas Device System Market, Sub-Segmentation Of Control-To-Target Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fully Closed-Loop Artificial Pancreas Systems
Insulin Pumps with Targeted Glucose Control
Automated Glucose Regulation Systems

7. Artificial Pancreas Device System Market Regional And Country Analysis

7.1. Global Artificial Pancreas Device System Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Artificial Pancreas Device System Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Pancreas Device System Market

8.1. Asia-Pacific Artificial Pancreas Device System Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Pancreas Device System Market

9.1. China Artificial Pancreas Device System Market Overview
9.2. China Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Pancreas Device System Market

10.1. India Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Pancreas Device System Market

11.1. Japan Artificial Pancreas Device System Market Overview
11.2. Japan Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Pancreas Device System Market

12.1. Australia Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Pancreas Device System Market

13.1. Indonesia Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Pancreas Device System Market

14.1. South Korea Artificial Pancreas Device System Market Overview
14.2. South Korea Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Pancreas Device System Market

15.1. Western Europe Artificial Pancreas Device System Market Overview
15.2. Western Europe Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Pancreas Device System Market

16.1. UK Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Pancreas Device System Market

17.1. Germany Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Pancreas Device System Market

18.1. France Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Pancreas Device System Market

19.1. Italy Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Pancreas Device System Market

20.1. Spain Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Pancreas Device System Market

21.1. Eastern Europe Artificial Pancreas Device System Market Overview
21.2. Eastern Europe Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Pancreas Device System Market

22.1. Russia Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Pancreas Device System Market

23.1. North America Artificial Pancreas Device System Market Overview
23.2. North America Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Pancreas Device System Market

24.1. USA Artificial Pancreas Device System Market Overview
24.2. USA Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Pancreas Device System Market

25.1. Canada Artificial Pancreas Device System Market Overview
25.2. Canada Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Pancreas Device System Market

26.1. South America Artificial Pancreas Device System Market Overview
26.2. South America Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Pancreas Device System Market

27.1. Brazil Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Pancreas Device System Market

28.1. Middle East Artificial Pancreas Device System Market Overview
28.2. Middle East Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Pancreas Device System Market

29.1. Africa Artificial Pancreas Device System Market Overview
29.2. Africa Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Pancreas Device System Market Competitive Landscape And Company Profiles

30.1. Artificial Pancreas Device System Market Competitive Landscape
30.2. Artificial Pancreas Device System Market Company Profiles
- 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. DexCom Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Insulet Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Pancreas Device System Market Other Major And Innovative Companies

31.1. Tandem Diabetes Care Inc.
31.2. Juvenile Diabetes Research Foundation (JDRF)
31.3. Beta Bionics Inc.
31.4. Glooko Inc.
31.5. Bigfoot Biomedical Inc.
31.6. CeQur SA
31.7. Medtrum Technologies Inc.
31.8. Diabeloop SA
31.9. Beta-O2 Technologies Ltd
31.10. Pancreum Inc.
31.11. TypeZero Technologies LLC
31.12. Inreda Diabetic B.V.
31.13. Defymed SAS
31.14. Admetsys Corporation
31.15. DreaMed Diabetes Ltd

32. Global Artificial Pancreas Device System Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Pancreas Device System Market

34. Recent Developments In The Artificial Pancreas Device System Market

35. Artificial Pancreas Device System Market High Potential Countries, Segments and Strategies

35.1 Artificial Pancreas Device System Market In 2029 - Countries Offering Most New Opportunities
35.2 Artificial Pancreas Device System Market In 2029 - Segments Offering Most New Opportunities
35.3 Artificial Pancreas Device System Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer